Concord Biotech Limited (BOM:543960)
India · Delayed Price · Currency is INR 1,264.00
+33.70 (2.74%)
At close: Jan 22, 2026
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 132.14 billion as of January 23, 2026. Its market cap has decreased by -39.39% in one year.
Market Cap
132.14B
Enterprise Value
128.84B
Revenue
11.25B
Ranking
n/a
PE Ratio
40.79
Stock Price
1,264.00
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 132.14B, an increase of 33.97%. That is a compound annual growth rate of 12.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 132.14B | -6.13% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 295.25B |
| AstraZeneca Pharma India | 206.24B |
| Jubilant Pharmova | 150.20B |
| Granules India | 134.12B |
| Caplin Point Laboratories | 132.36B |
| Rubicon Research | 109.37B |
| Sanofi India | 93.47B |
| Procter & Gamble Health | 90.41B |